Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France
PARIS (Reuters) – French President Emmanuel Macron will on Thursday
nordisk
Novo Nordisk to discontinue Levemir insulin in U.S. market
(Reuters) – Novo Nordisk said on Wednesday it would discontinue
Novo Nordisk, Lilly see insatiable demand for weight-loss drugs
By Maggie Fick and Bhanvi Satija (Reuters) – Novo Nordisk
US Patent Office won’t review two Novo Nordisk patents for Wegovy, Ozempic
By Blake Brittain WASHINGTON (Reuters) – A U.S. Patent Office
Europe will lose out on medical innovation if draft EU reforms pass, Novo Nordisk CEO says
By Maggie Fick LONDON (Reuters) – Europe will lose out
Novo Nordisk sees faster profit growth on demand for diabetes drug Ozempic
By Ludwig Burger (Reuters) – Danish drugmaker Novo Nordisk raised
Obesity drug supply delay not unusual says Novo Nordisk CEO
By Nikolaj Skydsgaard COPENHAGEN – Novo Nordisk sought to soothe